What if the mosquito net
wasn’t completely closed?

What if the mosquito net
wasn’t completely closed?

Japanese Encephalitis (JE) is an unpredictable but potentially devastating neurologic disease

A traveller to any of 24 countries in Asia can be infected with the JE virus, which is related to mosquito-borne Zika, dengue, yellow fever, and West Nile viruses. In rare cases, JE viral infection can result in encephalitis.

Travelling to a country in Asia?
Ask your healthcare professional
about the risks and benefits of
IXIARO®

Japanese Encephalitis (JE) is an unpredictable but potentially devastating neurologic disease

A traveller to any of 24 countries in Asia can be infected with the JE virus, which is related to mosquito-borne Zika, dengue, yellow fever, and West Nile viruses. In rare cases, JE viral infection can result in encephalitis.

Traveling to a country in Asia?
Ask your healthcare professional
about the risks and benefits of
IXIARO®

Watch real stories about the risks of JE

What do I need to know before travelling to Asia?

CLICK TO EXPAND

KEY FACTS ABOUT JAPANESE ENCEPHALITIS

Japanese encephalitis
is not just in Japan


The Japanese Encephalitis virus is endemic to more than 24 countries across Asia and Southeast Asia, as well as parts of the western Pacific

JE occurs across Asia

Over 70,000 symptomatic cases of JE are estimated to occur each year worldwide.

It is not possible to predict who will develop the disease – the majority of infections in humans are asymptomatic; clinical disease develops in one in every 50 to 1,000 individuals infected.

JE is the most common vaccine
-preventable encephalitis in Asia

JE is the leading cause of viral-induced neurologic disability.

Up to 30% of those who develop JE die,
and up to 50% of JE survivors suffer
long-term sequelae*

*Neurologic, cognitive, and psychiatric impairment

There is no specific
treatment for JE

Prevention is the best protection.

CLICK TO EXPAND

KEY FACTS ABOUT JAPANESE ENCEPHALITIS

Japanese encephalitis
is not just in Japan


The Japanese Encephalitis virus is endemic to more than 24 countries across Asia and Southeast Asia, as well as parts of the western Pacific

JE occurs across Asia

Over 70,000 symptomatic cases of JE are estimated to occur each year worldwide.

It is not possible to predict who will develop the disease – the majority of infections in humans are asymptomatic; clinical disease develops in one in every 50 to 1,000 individuals infected.

JE is the most common vaccine
-preventable encephalitis in Asia

JE is the leading cause of viral-induced neurologic disability.

Up to 30% of those who develop JE die,
and up to 50% of JE survivors suffer
long-term sequelae*

*Neurologic, cognitive, and psychiatric impairment

There is no specific
treatment for JE

Prevention is the best protection.

One vaccine can help
protect you

JE is a devastating yet
vaccine-preventable disease.

Got questions?
We’ve got answers.

What is IXIARO®?

Frequently Asked Questions

One vaccine can help
protect you

JE is a devastating yet
vaccine-preventable disease.

What is IXIARO?®

Got questions?
We’ve got answers.

Frequently Asked Questions

Where to get Ixiaro?

IXIARO® is a vaccine to help prevent Japanese Encephalitis (JE). IXIARO® is indicated for active immunization against Japanese Encephalitis Virus (JEV) for persons 2 months of age and older. IXIARO® should be considered for use in individuals at risk of exposure through travel or in the course of their occupation. As with any other vaccine, vaccination with IXIARO® may not result in protection in all cases. IXIARO® will not protect against encephalitis caused by other micro-organisms.

Allergic reaction may occur. In adults, very common side effects include headache, muscle pain, injection site reactions (pain, tenderness) and tiredness.
The most commonly reported side effects in children and adolescents include fever, diarrhea, influenza-like illness, irritability and injection site reactions (pain, tenderness, redness).

VALNEVA Canada Inc.
600-3535, Saint-Charles Blvd.
Kirkland (Montreal), Quebec
H9H 5B9

© 2022 VALNEVA Canada Inc.
All trademarks used under license.